Market Outlook 6th February 2012
-
Upload
angel-broking -
Category
Documents
-
view
220 -
download
0
Transcript of Market Outlook 6th February 2012
8/3/2019 Market Outlook 6th February 2012
http://slidepdf.com/reader/full/market-outlook-6th-february-2012 1/7
Please refer to important disclosures at the end of this report Sebi Registration No: INB 010996539 1
Market OutlookIndia Research
February 6, 2012
Dealer’s Diary
The domestic markets are expected to open in the green tracking gap up opening
in most of the Asian markets. Indian markets ended higher on Friday for a fourthday in a row on the back of heavy buying by FIIs.
Globally, most of the US and European markets closed higher as traders reacted
positively to a much better than expected report on the employment situation in the
US in the month of January. With the stronger than expected job growth, the
unemployment rate unexpectedly fell to 8.3% (lowest since February 2009) from
8.5% in the previous month. Also, a separate report from the Institute for Supply
Management showed that non-manufacturing index rose to 56.8 in January from a
revised 53.0 in December, with a reading above 50 indicating growth in the
service sector.
Indian investors this week, meanwhile, would keenly watch out for the domestic
industrial production growth for the month of December due to be released on
Friday. Also, consumer comfort index of US which will be released on comingThursday will be on radar.
Markets Today
The trend deciding level for the day is 17539 / 5,305 levels. If NIFTY trades above
this level during the first half-an-hour of trade then we may witness a further rally
up to 17,696 – 17,787 / 5,355 – 5,385 levels. However, if NIFTY trades below
17,539 / 5,305 levels for the first half-an-hour of trade then it may correct up to
17,448 – 17,292 / 5,276 – 5,226 levels.
Indices S2 S1 PIVOT R1 R2
SENSEX 17,292 17,448 17,539 17,696 17,787
NIFTY 5,226 5,276 5,305 5,355 5,385
News Analysis 3QFY2012 - Result Reviews – DRL, Madras Cements, HEG, TVS Srichakra,
Subros
3QFY2012 - Result Previews – HUL, Nalco, GSKCH, MOIL, India Cements,
BGR Energy, NCC, GIPCL
Refer detailed news analysis on the following page
Net Inflows (February 02, 2012)
` cr Purch Sales Net MTD YTD
FII 5,125 2,990 2,135 4,228 15,308
MFs 803 916 (113) 72 (1783)
FII Derivatives (February 03, 2012)
` cr Purch Sales Net Open Interest
Index Futures 1,590 1,482 107 12,408
Stock Futures 1,749 1,487 262 27,550
Gainers / Losers
Gainers Losers
Company Price (`) chg (%) Company Price (`) chg (%)
Bajaj Finserv 495 8.8 Reliance Comm 94 (3.3)
Tata Global 119 8.3 Hindalco Inds 153 (3.1)
CESC 269 6.9 Hindustan Copp 299 (3.0)India Cements 94 6.8 Financial Tech 775 (2.9)
Sintex Inds 98 6.6 Jindal Steel 556 (2.7)
Domestic Indices Chg (%) (Pts) (Close)
BSE Sensex 1.0 173.1 17,605
Nifty 1.1 56.0 5,326MID CAP 1.3 76.3 6,046
SMALL CAP 1.2 77.6 6,687
BSE HC 1.7 106.7 6,412
BSE PSU 1.1 80.4 7,486
BANKEX 1.4 163.5 11,644
AUTO 0.8 74.6 9,523
METAL (1.1) (131.1) 11,875
OIL & GAS 1.1 97.3 8,689
BSE IT 0.9 52.6 5,912
Global Indices Chg (%) (Pts) (Close)
Dow Jones 1.2 156.8 12,862
NASDAQ 1.6 46.0 2,906
FTSE 1.8 105.0 5,901
Nikkei (0.5) (44.9) 8,832
Hang Seng 0.1 17.5 20,757
Straits Times 0.6 16.9 2,918
Shanghai Com 0.8 17.9 2,330
Indian ADRs Chg (%) (Pts) (Close)
Infosys 2.9 1.6 $57.1
Wipro 2.1 0.2 $11.5
ICICI Bank 3.1 1.1 $38.3
HDFC Bank 3.4 1.1 $33.5
Advances / Declines BSE NSE
Advances 1,692
Declines 1,200 560
Unchanged 111 83
Volumes (` cr)
BSE 2,923
NSE 13,650
8/3/2019 Market Outlook 6th February 2012
http://slidepdf.com/reader/full/market-outlook-6th-february-2012 2/7
Market Outlook | India Research
February 6, 2012 2
3QFY2012 - Result Reviews
DRL
For 3QFY2012, DRL posted a good set of numbers, much ahead of ourexpectations. The company’s net sales came in at ` 2,769.2, growth of 46% yoy.
Growth was driven by U.S. sales, which grew by 120% yoy. Other key
geographies apart from Europe grew in double digits. Growth in the U.S. was led
by the high value launch of Olanzapine 20 mg, new products launched in the
past 12 months and strong volume growth across key products. This also aided
significant improvement in the company’s gross margin and subsequently in
OPM. The company’s OPM expanded by 12% yoy to 27%. Consequently, net
profit grew by 88% yoy during the period. We maintain our Buy rating on the
stock. The target price is under review.
Madras Cements
During 3QFY2012, Madras Cements’ top line rose by 27.9% yoy to ` 741cr. The
cement business posted 29.4% yoy growth in net sales to ` 733cr on account of
19.1% yoy growth in dispatches (on a low base) and 8.6% yoy growth in
realizations. The wind division’s revenue decreased by 38.8% yoy to ` 7.7cr.
Improved cement realization aided OPM to grow by 243bp to 28.0%, amidst cost
pressures felt in freight expenses and other costs. The company’s bottom line
increased by 76.7% yoy to ` 77cr. We maintain our Neutral view on the stock.
HEG
HEG Ltd. reported revenue growth of 35% yoy to ` 418cr for 3QFY2012
from ` 310cr in 3QFY2011 due to increased prices of graphite electrodes and
over 100% capacity utilization for the quarter. OPM for the quarter contracted by
1,059bp to 11.9% in 3QFY2012 from 22.4% in 3QFY2011 on account of higher
other expenses and forex loss of ` 35.5cr. PAT dipped by 37% yoy to ` 24cr as
compared to ` 38cr in 3QFY2011. Tax rate was lower at 12% for the quarter
compared to 21% in 3QFY2011. We maintain our Buy rating on the stock with a
revised target price of `236, based on a target P/B of 1.0x for FY2013E.
TVS Srichakra
For 3QFY2012, TVS Srichakra reported a mixed set of numbers. The company
reported 21.1% yoy growth in its net sales, from ` 287cr in 3QFY2011 to ` 348cr
in 3QFY2012. Net raw-material cost for the company increased by 23.7% yoy.
Increased net raw-material cost along with higher other expenditure by 22.3% yoy
led to a substantial decline in the operating profit of the company. Operating
profit margin stood at 7.1%, a decline of 95bp yoy and 220bp qoq. The
company’s profit declined by 33.1% yoy to ` 7cr, which was ` 10cr in the same
quarter last year. We maintain our Buy recommendation on the stock. The stock
price is under review.
8/3/2019 Market Outlook 6th February 2012
http://slidepdf.com/reader/full/market-outlook-6th-february-2012 3/7
Market Outlook | India Research
February 6, 2012 3
Subros
Subros reported poor results for 3QFY2012, led by a yoy decline in volumes and
increased interest expense. However, on a sequential basis, higher interest cost
and depreciation expense impacted the company’s performance. Subros reported
a 7.1% yoy decline in its net sales to ` 254cr due to a 13% yoy drop in volumes.
Net average realization improved by 6.7% yoy, thereby preventing further decline
in the top line. On a sequential basis, net sales increased by 5.5% on account of
a 9.1% increase in volumes. Operating margin improved by 107bp yoy (62bp
qoq) to 8.5%, driven by raw-material cost savings (raw-material to sales ratio
declined by 381bp yoy) due to commencement of local production of certain
components (mainly evaporators). On the other hand, a 266bp yoy increase in
staff cost restricted margin expansion to a certain extent. Net profit nosedived by
steep 62.5% yoy (33.7% qoq) to ` 2.1cr on account of an 88.1% yoy (21.3% qoq)
increase in interest cost. The stock rating is currently under review.
3QFY2012 - Result Previews
HUL
HUL is expected to announce its 4QFY2011 results. We expect the company to
report a healthy 15.7% yoy growth rate in its revenue to ` 5,815cr and a 107bp
yoy expansion in its operating margin to 13.1%. The company is expected to
report 15.7% yoy growth in recurring earnings, owing to healthy revenue traction
and an expansion in margins. We maintain our Neutral view on the stock.
Nalco
Nalco is slated to report its 3QFY2012 results. We expect net sales to increase by
24.2% yoy to ` 1,770cr. However, EBITDA margin is expected to contract by
1,034bp yoy to 17.0% due to rise in prices of key inputs (primarily coal). Net
profit is expected to decrease by 12.4% yoy to ` 224cr. We maintain our Neutral
view on the stock.
GSKCH – 4QCY2011
GSK Consumer (GSKCH) is slated to announce its 4QCY2011 numbers. For the
quarter, we expect GSKCH to post healthy growth of 20% yoy in its top line to
` 610cr, driven by growth in its core brands and new product launches. The
bottom line is expected to register growth of 17.9% yoy to ` 63cr, aided by
top-line growth and margin expansion of 24bp yoy to 11.8%. We maintain our
Neutral view on the stock.
8/3/2019 Market Outlook 6th February 2012
http://slidepdf.com/reader/full/market-outlook-6th-february-2012 4/7
Market Outlook | India Research
February 6, 2012 4
MOIL
MOIL is slated to report its 3QFY2012 results. We expect net sales to decline by
2.1% yoy to ` 248cr, mainly on account a decline in manganese ore prices.
Nevertheless, EBITDA margin is expected to improve by 120bp yoy to 47.0% in
3QFY2012. Net profit is expected to increase by 0.4% yoy to ` 106cr. We
maintain our Neutral view on the stock.
India Cements
India Cements is expected to announce its 3QFY2012 results. We expect the
company’s top line to grow by 18% yoy to ` 922cr, primarily on account of 15.4%
yoy growth in realization (though on a lower base of last year). The company’s
margin is expected to improve by 220bp yoy to 14.3%, aided by higher
realization. The company’s net profit is expected to grow by 19.2% yoy to ` 26cr.
We maintain our Neutral rating on the stock.
BGR Energy
For 3QFY2012, we expect BGR Energy's (BGR) top line to be under pressure due
to high base created in 3QFY2011 and partly due to execution delays. The top
line is expected to decline by 28.3% yoy to ` 901.1cr. EBITDA margin is expected
to come in at 12.0%. Interest cost is expected to stretch further (owing to hike in
interest rates and enhanced working capital debt levels); which, along with
slumped revenue, is likely to drag the bottom line down by 46.1% yoy to ` 47.2cr.
At the CMP, the stock is trading at 6.7x and 7.2x FY2012E and Fy2013E EPS,
respectively. Currently, we remain Neutral on the stock.
Nagarjuna Construction Company
We expect subdued performance from Nagarjuna Construction (NCC) for this
quarter. On the top-line front, NCC is expected to post a yoy decline of 9.0% to
` 1,215cr. EBITDA margin is expected to be flat at 9.5%. On the earnings front,
we expect NCC to post a decline of 65.4% yoy to ` 14.0cr for the quarter. This
would be primarily due to burgeoning interest cost (yoy jump of ~73.2%) and a
decline in the company’s top line. Owing to the sharp run up in the stock price,
we recommend Neutral on the stock.
GIPCL
GIPCL is expected to announce its 3QFY2012 results. The company is expected to
register 15.5% yoy growth in its revenue to ` 353cr, primarily on the back of
higher volumes from 250MW SLPP station II. OPM is set to expand by 633bp to
33.1% due to higher availability of Surat II station. The company’s bottom line is
expected to improve by 52.6% yoy to ` 37cr in 3QFY2012. We maintain our Buy
rating on the stock with a target price of `95.
8/3/2019 Market Outlook 6th February 2012
http://slidepdf.com/reader/full/market-outlook-6th-february-2012 5/7
Market Outlook | India Research
February 6, 2012 5
Quarterly Bloomberg Brokers’ Consensus Estimates
Adani Power Ltd - (06/02/2012)
Particulars (` cr) 3Q FY12E 3Q FY11 y-o-y (%) 2Q FY12 q-o-q (%)
Net sales 1,098 503 118 1,072 2
EBITDA 526 273 93 519 1
EBITDA margin (%) 47.9 54.3 48.4
Net profit 211 109 94 177 19
Adani Ports & SEZ Ltd - (06/02/2012)
Particulars (` cr) 3Q FY12E 3Q FY11 y-o-y (%) 2Q FY12 q-o-q (%)
Net sales 643 421 53 588 9
EBITDA 440 310 42 411 7
EBITDA margin (%) 68.4 73.6 69.9
Net profit 303 228 33 273 11
Hindustan Unilever Ltd - (06/02/2012)
Particulars (` cr) 3Q FY12E 3Q FY11 y-o-y (%) 2Q FY12 q-o-q (%)
Net sales 5,879 5,027 17 5,522 6
EBITDA 857 725 18 827 4
EBITDA margin (%) 14.6 14.4 15.0
Net profit 700 638 10 689 2
Mahindra & Mahindra Ltd - (07/02/2012)Particulars (` cr) 3Q FY12E 3Q FY11 y-o-y (%) 2Q FY12 q-o-q (%)
Net sales 7,985 6,074 31 7,307 9
EBITDA 998 924 8 874 14
EBITDA margin (%) 12.5 15.2 12.0
Net profit 687 735 (7) 737 (7)
GMR Infra Ltd - Consolidated (07/02/2012)
Particulars (` cr) 3Q FY12E 3Q FY11 y-o-y (%) 2Q FY12 q-o-q (%)
Net sales 1,814 1,359 33 1,812 0
EBITDA 513 381 34 501 2
EBITDA margin (%) 28.3 28.1 27.7
Net profit (63) (22) 184 (63) 1
Power Grid Corporation Ltd - (08/02/2012)
Particulars (` cr) 3Q FY12E 3Q FY11 y-o-y (%) 2Q FY12 q-o-q (%)
Net profit 739 591 25 709 4
8/3/2019 Market Outlook 6th February 2012
http://slidepdf.com/reader/full/market-outlook-6th-february-2012 6/7
Market Outlook | India Research
February 6, 2012 6
Bharti Airtel Ltd - Consolidated (08/02/2012)
Particulars (` cr) 3Q FY12E 3Q FY11 y-o-y (%) 2Q FY12 q-o-q (%)
Net sales 18,427 15,759 17 17,270 7
EBITDA 6,288 5,021 25 5,815 8EBITDA margin (%) 34.1 31.9 33.7
Net profit 1,347 1,303 3 1,027 31
ONGC Ltd - (08/02/2012)
Particulars (` cr) 3Q FY12E 3Q FY11 y-o-y (%) 2Q FY12 q-o-q (%)
Net sales 21,127 18,586 14 22,616 (7)
EBITDA 13,119 13,531 (3) 14,469 (9)
EBITDA margin (%) 62.1 72.8 64.0
Net profit 6,859 7,083 (3) 8,642 (21)
Economic and Political News
Court quashes Swamy's petition, relief for Chidambaram
Global food prices to ease in 2012: World Bank
Government may lower STT in Budget to boost markets
GoM meeting on ATF import, FDI, AI on Thursday
Corporate News
Central Bank of India may recast loans to power utilities
Fortis invests ` 274cr in two Singapore healthcare ventures Mundra project may become an NPA: Tata Power
Reliance Industries to charge US$0.15 marketing margin on CBM gas Source: Economic Times, Business Standard, Business Line, Financial Express, Mint
Results Calendar
06/02/2012HUL, Mundra Port, Adani Power, Nalco, GlaxoSmith Con, MOIL, Dena Bank, BGR Energy , India Cements,Nagarjuna Const., GIPCL
07/02/2012 M&M, Cadila Healthcare, GMR Infra., ITNL, SpiceJet, J K Lakshmi Cements
08/02/2012 ONGC, Bharti Airtel, Power Grid Corpn, Bharat Forge, Orchid Chemicals, Alembic Pharma
09/02/2012 Adani Enterp., Tata Steel, Hindalco, Ambuja Cements, ACC, HPCL, Cummins India, Tech Mahindra, GSPL, PageIndustries, Apollo Tyres, FAG Bearings, Dishman Pharma, JK Tyre
09/02/2012 Tata Power Co., BPCL, IDFC, Shriram Trans., JSW Steel , Sun TV Network, Britannia, Aurobindo Pharma
10/02/2012Reliance Capital, Pantaloon Retail, Aurobindo Pharma, Eros International, BPCL, Apollo Hospitals, Britannia,MTNL, SUN TV, Tata Power, RCom
8/3/2019 Market Outlook 6th February 2012
http://slidepdf.com/reader/full/market-outlook-6th-february-2012 7/7
Market Outlook | India Research
February 6, 2012 7
Research Team Tel: 022 - 39357800 E-mail: [email protected] Website: www.angelbroking.com
DISCLAIMER
This document is solely for the personal information of the recipient, and must not be singularly used as the basis of any investment
decision. Nothing in this document should be construed as investment or financial advice. Each recipient of this document should make
such investigations as they deem necessary to arrive at an independent evaluation of an investment in the securities of the companies
referred to in this document (including the merits and risks involved), and should consult their own advisors to determine the merits and
risks of such an investment.
Angel Broking Limited, its affiliates, directors, its proprietary trading and investment businesses may, from time to time, make
investment decisions that are inconsistent with or contradictory to the recommendations expressed herein. The views contained in this
document are those of the analyst, and the company may or may not subscribe to all the views expressed within.
Reports based on technical and derivative analysis center on studying charts of a stock's price movement, outstanding positions and
trading volume, as opposed to focusing on a company's fundamentals and, as such, may not match with a report on a company's
fundamentals.
The information in this document has been printed on the basis of publicly available information, internal data and other reliablesources believed to be true, but we do not represent that it is accurate or complete and it should not be relied on as such, as thisdocument is for general guidance only. Angel Broking Limited or any of its affiliates/ group companies shall not be in any way responsible for any loss or damage that may arise to any person from any inadvertent error in the information contained in this report .
Angel Broking Limited has not independently verified all the information contained within this document. Accordingly, we cannot testify,nor make any representation or warranty, express or implied, to the accuracy, contents or data contained within this document. While Angel Broking Limited endeavours to update on a reasonable basis the information discussed in this material, there may be regulatory,compliance, or other reasons that prevent us from doing so.
This document is being supplied to you solely for your information, and its contents, information or data may not be reproduced,
redistributed or passed on, directly or indirectly.
Angel Broking Limited and its affiliates may seek to provide or have engaged in providing corporate finance, investment banking or
other advisory services in a merger or specific transaction to the companies referred to in this report, as on the date of this report or in
the past.
Neither Angel Broking Limited, nor its directors, employees or affiliates shall be liable for any loss or damage that may arise from or in
connection with the use of this information.
Note: Please refer to the important `Stock Holding Disclosure' report on the Angel website (Research Section). Also, please refer to thelatest update on respective stocks for the disclosure status in respect of those stocks. Angel Broking Limited and its affiliates may haveinvestment positions in the stocks recommended in this report.